Current understanding of thrombosis and hemostasis — from bench to bedside von Willebrand factor : at the crossroads of bleeding and thrombosis
暂无分享,去创建一个
[1] C. Casari,et al. Clearance of von Willebrand factor , 2013, Journal of thrombosis and haemostasis : JTH.
[2] G. Gambaro,et al. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure. , 2012, The Biochemical journal.
[3] D. Wagner,et al. Neutrophil extracellular traps promote deep vein thrombosis in mice , 2012, Journal of thrombosis and haemostasis : JTH.
[4] D. Wagner,et al. Histones induce rapid and profound thrombocytopenia in mice. , 2011, Blood.
[5] D. Lane,et al. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. , 2011, Blood.
[6] Hiroshi Uji-i,et al. Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis* , 2011, The Journal of Biological Chemistry.
[7] D. Tregouet,et al. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels , 2011, BMC Medical Genetics.
[8] K. Ghosh,et al. Pathophysiology of acquired von Willebrand disease: a concise review , 2011, European journal of haematology.
[9] A. Iorio,et al. Management of Inherited von Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients , 2011, Seminars in thrombosis and hemostasis.
[10] R. Schneppenheim,et al. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein , 2011, Journal of thrombosis and haemostasis : JTH.
[11] T. Springer,et al. Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.
[12] A. Ganser,et al. How I treat the acquired von Willebrand syndrome. , 2011, Blood.
[13] D. Strachan,et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.
[14] F. Leebeek,et al. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review , 2011, Journal of thrombosis and haemostasis : JTH.
[15] D. Lillicrap,et al. Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models. , 2011, Blood.
[16] D. Motto,et al. Modulation of von Willebrand Factor by ADAMTS13 , 2011 .
[17] J. Moake,et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. , 2011, The Journal of clinical investigation.
[18] B. Lämmle,et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. , 2011, Blood.
[19] A. Tosetto,et al. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance , 2011, Thrombosis and Haemostasis.
[20] J. Moake,et al. Disulfide bond reduction of von Willebrand factor by ADAMTS‐13 , 2010, Journal of thrombosis and haemostasis : JTH.
[21] P. Lenting,et al. ADAMTS‐13: double trouble for von Willebrand factor , 2010, Journal of thrombosis and haemostasis : JTH.
[22] D. Strachan,et al. Effect of Genetic Variations in Syntaxin-Binding Protein-5 and Syntaxin-2 on von Willebrand Factor Concentration and Cardiovascular Risk , 2010, Circulation. Cardiovascular genetics.
[23] Junmei Chen,et al. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. , 2010, Blood.
[24] G. Stoll,et al. Binding of von Willebrand Factor to Collagen and Glycoprotein Ib&agr;, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[25] M. Slaughter. Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.
[26] J. Hartwig,et al. Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.
[27] P. D. de Groot,et al. Regulation of von Willebrand factor-platelet interactions , 2010, Thrombosis and Haemostasis.
[28] P. Legendre,et al. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. , 2010, Blood.
[29] R. Hoffmann,et al. Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD , 2010, Journal of thrombosis and haemostasis : JTH.
[30] Andrew D. Johnson,et al. Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium , 2010, Circulation.
[31] S. Rutella,et al. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. , 2010, Free radical biology & medicine.
[32] Junmei Chen,et al. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. , 2010, Blood.
[33] Y. Asada,et al. Critical role of von Willebrand factor and platelet interaction in venous thromboembolism. , 2009, Histology and histopathology.
[34] F. Rosendaal,et al. Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men. , 2009, Blood.
[35] M. Laffan,et al. Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. , 2009, Blood.
[36] Cheng-Zhong Zhang,et al. Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.
[37] G. Stoll,et al. Deficiency of von Willebrand factor protects mice from ischemic stroke. , 2009, Blood.
[38] H. Deckmyn,et al. Von Willebrand factor: drug and drug target. , 2009, Cardiovascular & hematological disorders drug targets.
[39] P. Mannucci,et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. , 2009, Blood.
[40] Z. Ruggeri. Platelet Adhesion under Flow , 2009, Microcirculation.
[41] A. Reininger. Function of von Willebrand factor in haemostasis and thrombosis , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[42] N. Lamblin,et al. Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction , 2008, Circulation.
[43] O. Christophe,et al. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. , 2008, Blood.
[44] J. Moake,et al. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions , 2008, Journal of thrombosis and haemostasis : JTH.
[45] J. Goudemand,et al. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). , 2008, Blood.
[46] P. D. de Groot,et al. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. , 2007, Blood.
[47] P. Lenting,et al. Clearance mechanisms of von Willebrand factor and factor VIII , 2007, Journal of thrombosis and haemostasis : JTH.
[48] A Alexander-Katz,et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.
[49] P. Legendre,et al. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS‐13 , 2007, Journal of thrombosis and haemostasis : JTH.
[50] P. Hogg,et al. Hypothesis for control of von Willebrand factor multimer size by intra‐molecular thiol‐disulphide exchange , 2007, Journal of thrombosis and haemostasis : JTH.
[51] P. Mannucci,et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.
[52] R. Paschke,et al. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[53] P. D. de Groot,et al. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. , 2005, Blood.
[54] P. Lenting,et al. Cysteine‐mutations in von Willebrand factor associated with increased clearance , 2005, Journal of thrombosis and haemostasis : JTH.
[55] A. Hofman,et al. Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study , 2004, British journal of haematology.
[56] S. Susen,et al. Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.
[57] A. Folsom,et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.
[58] A. Sala,et al. Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis , 2000, Circulation.
[59] A. Ahlbom,et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[60] G. Chatellier,et al. Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes , 2000 .
[61] L. Bouter,et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[62] M. Furlan,et al. Von Willebrand factor: molecular size and functional activity , 1996, Annals of Hematology.
[63] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[64] Z. Ruggeri,et al. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. , 1993, Blood.
[65] D. Morgan,et al. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? , 1992, The Lancet.
[66] C. Richard,et al. Acquired von willebrand disease in multiple myeloma secondary to absorption of von willebrand factor by plasma cells , 1990, American journal of hematology.
[67] A. K. Banerjee. Angiodysplasia associated with hypertrophic obstructive cardiomyopathy (HOCM) , 1990, The British journal of clinical practice.
[68] C. Rothschild,et al. New variant of von Willebrand disease with defective binding to factor VIII. , 1989, Blood.
[69] R. Montgomery,et al. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. , 1986, Blood.
[70] D. Deykin,et al. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. , 1982, The New England journal of medicine.
[71] A. Chauhan,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins , 2007 .
[72] R. Schneppenheim,et al. Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update. , 2005, Seminars in hematology.
[73] C. Denis. Molecular and Cellular Biology of von Willebrand Factor , 2002, International journal of hematology.
[74] A. Girolami,et al. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. , 2002, Blood.
[75] G. Chatellier,et al. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. , 2000, Kidney international.
[76] Z. Ruggeri,et al. The complex multimeric composition of factor VIII/von Willebrand factor. , 1981, Blood.